4.3 Editorial Material

Updates of incretin-related drugs for the treatment of type 2 diabetes

Journal

JOURNAL OF DIABETES INVESTIGATION
Volume 14, Issue 2, Pages 189-192

Publisher

WILEY
DOI: 10.1111/jdi.13945

Keywords

Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonists; Glucose-dependent insulinotropic polypeptide receptor

Ask authors/readers for more resources

This article explores the mechanisms of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor dual-agonists in glycemic control and/or weight loss.
Mechanisms of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists and glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor dual-agonist in glycemic control and/or weight loss.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available